425: Strive and Semler Scientific Merger: Risks and Outlook

Strive, Inc. and Semler Scientific, Inc. communicate proposed business combination details, highlighting strategic benefits and associated risks.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• Ben Pham, CFO of Strive, Inc., reposted a communication on X.com on December 18, 2025, regarding the proposed transaction.
• The communication includes a cautionary statement about forward-looking statements, emphasizing inherent risks and uncertainties.
• The proposed transaction is expected to yield strategic and financial benefits, including anticipated cost savings and strategic gains.
• Strive has filed a Registration Statement on Form S-4 with the SEC to register Class A common stock for the transaction, which includes an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus was sent to Semler Scientific stockholders for approval of the proposed transaction.
• Investors and stockholders are urged to read all relevant SEC filings before making voting or investment decisions.

Sentiment

Score: 5

Explanation: The filing is a formal communication about a proposed merger, heavily weighted with cautionary statements and risks. While the underlying event is significant, the document's tone is neutral to cautious, focusing on legal disclosures rather than promotional aspects.

Positives

• Anticipated strategic benefits from the proposed business combination.
• Expected financial benefits, including anticipated cost savings and strategic gains, from the proposed transaction.
• The ability to successfully integrate the combined businesses is a stated objective.

Negatives

• Potential for diversion of management's attention from ongoing business operations and opportunities due to the transaction.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including cost savings and successful integration of businesses. However, they also acknowledge significant risks and uncertainties that could impact the timing, realization of benefits, and overall success of the merger.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., reposted the communication on X.com on December 18, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The filing mentions risks associated with 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' indicating Strive's engagement with digital asset strategies, a growing trend for some companies seeking alternative treasury management or investment approaches.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Potential changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Dilution for existing Strive shareholders due to the issuance of new Class A common stock.

Next Steps

• Semler Scientific stockholders need to approve the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus and any amendments or supplements.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.

Key Dates

Recommendation

The filing details a proposed business combination, a significant event that could impact both companies. However, it is primarily a cautionary statement outlining numerous risks and uncertainties associated with the merger's completion, integration, and realization of benefits. Without specific financial terms or updated operational performance, a 'hold' recommendation is prudent, advising investors to await further definitive information and the outcome of the shareholder vote, while carefully considering the highlighted risks.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Corporate Governance, Risk Factors, Bitcoin Treasury, Digital Assets